APA (7th ed.) Citation

Pavo, N., Cho, A., Wurm, R., Strunk, G., Krauth, M., Agis, H., & Hülsmann, M. (2018). N‐terminal B‐type natriuretic peptide (NT‐proBNP) is associated with disease severity in multiple myeloma. European Journal of Clinical Investigation, 48(4), 1. https://doi.org/10.1111/eci.12905

Chicago Style (17th ed.) Citation

Pavo, Noemi, Anna Cho, Raphael Wurm, Guido Strunk, Maria Krauth, Hermine Agis, and Martin Hülsmann. "N‐terminal B‐type Natriuretic Peptide (NT‐proBNP) Is Associated with Disease Severity in Multiple Myeloma." European Journal of Clinical Investigation 48, no. 4 (2018): 1. https://doi.org/10.1111/eci.12905.

MLA (9th ed.) Citation

Pavo, Noemi, et al. "N‐terminal B‐type Natriuretic Peptide (NT‐proBNP) Is Associated with Disease Severity in Multiple Myeloma." European Journal of Clinical Investigation, vol. 48, no. 4, 2018, p. 1, https://doi.org/10.1111/eci.12905.